Robin Jones, MBBS, MRCP, MD, The Royal Marsden Hospital, London, UK, explores the evolving treatment landscape for patients with advanced gastrointestinal stromal tumor (GIST), including novel agents in development and the promise of ctDNA in the management of this rare disease. This interview took place at the American Society of Clinical Oncology (ASCO) 2023 Annual Congress in Chicago, IL.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
